FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes
Hand-out
Press Releases
U.S. Food and Drug Administration  
February 14, 2025

FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

Agency Continues Efforts to Increase Access to Insulin Treatment Options

avatar profile Olean Times Herald

Olean Times Herald


Local & Social